The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 10, 1997, Pages 2127-2131

  Lin, Alice H ^a   Murray, Robert W ^a   Vidmar, Thomas J ^a   Marotti, Keith R ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; EPEREZOLID; LINCOMYCIN; OXAZOLIDINE DERIVATIVE; PUROMYCIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING COMPETITION; BINDING KINETICS; DRUG BINDING; DRUG MECHANISM; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RIBOSOME SUBUNIT;

EID: 0030773903     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.10.2127     Document Type: Article

References (26)

1. Barbachyn, M. R., D. K. Hutchinson, S. J. Brickner, M. H. Cynamon, O. J. Kilburn, S. P. Klemens, S. E. Glickman, K. C. Grega, S. K. Hendges, D. S. Toops, C. W. Ford, and G. E. Zurenko. 1996. Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity. J. Med. Chem. 39:680-685.
2. Barry, A. L. 1988. In vitro evaluation of DuP 105 and DuP 721, two new oxazolidinone antimicrobial agents. Antimicrob. Agents Chemother. 32:150-152.
3. Barta, A., E. Kuechler, and G. Steiner. 1990. Photoaffinity labeling of the peptidyltransferase region, p. 358-365. In W. E. Hill, A. Dahlberg, R. A. Garret, P. B. Moore, D. Schlessinger, and J. R. Warner (ed.), The ribosome. American Society for Microbiology, Washington, D.C.
4. Brickner, S. J., D. K. Hutchinson, M. R. Barbachyn, P. R. Manninen, D. A. Ulanowicz, S. A. Garmon, K. C. Grega, S. K. Hendges, D. S. Toops, C. W. Ford, and G. E. Zurenko. 1996. Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. J. Med. Chem. 39:673-679.
5. Brumfitt W., and J. M. T. Hamilton-Miller. 1992. Antibacterial oxazolidinones in vitro activity of a new analogue, E3709. Diagn. Microbiol. Infect. Dis. 15:621-625.
6. Cannon, M. 1968. The puromycin reaction and its inhibition by chloramphenicol. Eur. J. Biochem. 7:137-145.
7. Caskey, C. T., and A. L. Beaudet. 1971. Antibiotic inhibitors of peptide termination, p. 326-336. In E. Munoz, F. Garcias-Fernandez, and D. Vasquez (ed.), Molecular mechanisms of antibiotic action on protein biosynthesis and membranes. Elsevier, Amsterdam, The Netherlands.
8. Cundliffe, E., and K. McQuillen. 1967. Bacterial protein synthesis: the effects of antibiotics. J. Mol. Biol. 30:137-146.
9. Daly, J. S., G. M. Eliopoulos, E. Reiszner, and R. C. Moellering. 1988. Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compounds. Antimicrob. Agents Chemother. 21:721-730.
10. Daly, J. S., G. M. Eliopoulos, S. Willey, and R. C. Moellering, Jr. 1988. Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compound. Antimicrob. Agents Chemother. 32:1341-1346.
11. Douthwaite, S. 1992. Interaction of the antibiotics clindamycin and lincomycin with Escherichia coli 23S ribosomal RNA. Nucleic Acids Res. 20:4717-4720.
12. Eustice, D. C., P. A. Feldman, I. Zajac, and A. M. Slee. 1988. Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesis. Antimicrob. Agents Chemother. 32:1218-1222.
13. Eustice, D. C., P. A. Feldman, and A. M. Slee. 1988. The mechanism of action of DuP 721, a new antibacterial agent: effects on macromolecular synthesis. Biochem. Biophys. Res. Commun. 150:965-971.
14. Fernandez-Munoz, R., R. E. Monro, R. Torres-Pinedo, and D. Vazquez. 1971. Substrate- and antibiotic-binding sites at the peptidyl-transferase centre of Escherichia coli ribosomes. Studies on the chloramphenicol, lincomycin and erythromycin sites. Eur. J. Biochem. 23:185-193.
15. Franklin, T. J., and G. A. Snow. 1981. Interference with the translation of the genetic message: inhibitors of protein synthesis, p. 110-137. In Biochemistry of antimicrobial action. Chapman & Hall, New York, N.Y.
16. Ganoza, M. C., D. Buckingham, P. Hader, and T. Neilson. 1984. Effect of base sequence on in vitro protein-chain termination. J. Biol. Chem. 259: 14101-14104.
17. Lancini, G. F., G. Parenti, and G. Gallo. 1995. The mechanism of action of antibiotics, p. 37-83. In Antibiotics: a multidisciplinary approach. Plenum Press, New York, N.Y.
18. Mini, E., A. Novelli, T. Mazzei, and P. Periti. 1989. Comparative in vitro activity of the new oxazolidinones DuP 721 and DuP 105 against Staphylococci and Streptococci. Eur. J. Clin. Microbiol. Infect. Dis. 8:256-260.
19. Moazed, D., and H. F. Noller. 1987. Chloramphenicol, erythromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosmal RNA. Biochimie 69:879-884.
20. Nathans, D., and F. Lipmann. 1961. Amino acid transfer from aminoacylribonucleic acids to protein on ribosomes of Escherichia coli. Proc. Natl. Acad. Sci. USA 47:497-504.
21. Pongs, O., R. Bald, and V. A. Erdmann. 1973. Identification of chloramphenicol-binding protein in Escherichia coli ribosomes by affinity labeling. Proc Natl. Acad. Sci. USA 70:2229-2233.
22. Randall-Hazelbauer, L. L., and C. G. Kurland. 1972. Identification of three 30S proteins contributing to the ribosomal A site. Mol. Gen. Genet. 115: 234-242.
23. Scatchard, G. 1949. The attraction of proteins for small molecules and ions. Ann N. Y. Acad. Sci. 51:660-672.
24. Slee A. M., M. A. Wuonola, R. J. McRipley, I. Zajac, M. J. Zawads, P. T. Bartholomew, W. A. Gregory, and M. Forbes. 1987. Oxazolidinones, a new class of synthetic antibacterial agents: in vitro activities of DuP 105 and DuP 721. Antimicrob. Agents Chemother. 31:1791-1797.
25. Smith, J. D., R. R. Traut, G. M. Blackburn, and R. E. Monro. 1965. Action of puromycin in polyadenylic acid-directed polylysine synthesis. J. Mol. Biol. 13:617-628.
26. Tate, W. P., and C. T. Caskey. 1990. Termination of protein synthesis, p. 81-100. In G. Spedding (ed.), Ribosomes and protein synthesis: a practical approach. Oxford University Press, New York, N.Y.